India’s acute shortage of COVID-19 vaccines boosts pharma profits

India’s acute shortage of COVID-19 vaccines is helping pharma giants to profiteer, while the Modi regime remains elusive about universal vaccination drive

Support People's Review

Please support us in publishing more impactful stories with a new perspective. Your support can help us sustain and take this endeavour ahead.

Payment from outside India is not accepted now as we are not registered under the FCRA